1 Min Read
May 10 (Reuters) - Biocon Ltd
* Says Biocon statement in response to media reports on USFDA form 483s for Biocon Limited
* Says co had already responded to USFDA on all observations of recent audit Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.